Real-Time News FIRE FAST SIP Calculators

Easy-to-understand Financial Insights
that build Wealth.

Explore Dzambhala NodeX

SUNPHARMA

NSE: SUNPHARMA | BSE: 524715

Latest on SUNPHARMA

Sun Pharma Reports ₹1,37,861 Million Q1 FY26 Sales, Net Profit Up 16.6% August 6, 2025 | 5:19 p.m. IST
Sun Pharma Promoter Pledges 6.5 Lac Shares for Loan Facility August 4, 2025 | 10:22 a.m. IST
Mankind Pharma Reports Q1 FY 2025-26 Revenue of ₹3,570.35 Cr and Net Profit of ₹444.62 Cr August 1, 2025 | 6:59 p.m. IST
Sun Pharma Declares Final Dividend of ₹5.50 Per Share and Reports 9% Revenue Growth to ₹520 Billion in 33rd AGM July 31, 2025 | 7:11 p.m. IST
Sun Pharma Reports Q1FY26 Earnings With ₹29,961 Million Net Profit and 10.1% Sales Growth July 31, 2025 | 2:49 p.m. IST
Sun Pharma Reports Q1FY26 Results with ₹29,961 Million Adjusted Net Profit and 10.1% Growth in Gross Sales July 31, 2025 | 2:36 p.m. IST
Sun Pharma To Pay ₹1,650 Cr To Settle U.S. Antitrust Litigation Over Generic Drug Pricing July 24, 2025 | 4:56 p.m. IST
Sun Pharma Reports Successful Phase 3 Trials of Tildrakizumab for Active Psoriatic Arthritis July 21, 2025 | 8:27 a.m. IST
Sun Pharma Opens Special Six-Month Window for Share Transfers of Physical Shares Lodged Before April 2019 July 19, 2025 | 2:34 p.m. IST
Sun Pharma Incorporates 100% Owned Subsidiary in China to Localise Products July 17, 2025 | 6:59 p.m. IST
Sun Pharma Reports FY25 Sales of ₹520 Billion and Net Profit of ₹109 Billion in Investor Presentation July 14, 2025 | 6:53 p.m. IST
Sun Pharma Launches LEQSELVI™ in US, Offering New Hope for Alopecia Areata Patients July 14, 2025 | 4:48 p.m. IST
Sun Pharma Settles Litigation with Incyte, Secures Non-Exclusive License for LEQSELVI™ July 14, 2025 | 4:36 p.m. IST
Sun Pharma To Approve Q1 Financial Results On 31 July, Trading Window Closed Until 2 August July 11, 2025 | 5:56 p.m. IST
Sun Pharma Publishes Positive Phase 2b Results for MM-II, Aiming for Fast Track FDA Approval April 24, 2025 | 8:44 a.m. IST
Sun Pharma Cleared To Launch LEQSELVI™ In The US After Court Ruling April 10, 2025 | 5:09 p.m. IST
Sun Pharma Launches Fexuclue® to Treat Erosive Esophagitis, Promising Rapid Healing for Patients April 7, 2025 | 8:48 a.m. IST
Sun Pharma Pledges 14 Lac Shares as Security for Loan Facilities to Third Party April 2, 2025 | 11:49 a.m. IST
Sun Pharma Sees Board Changes as Sanjay Asher Retires and Rama Bijapurkar Joins Audit Committee March 31, 2025 | 7:33 p.m. IST
Sun Pharma Pledges 15 Lac Shares as Security for Third-Party Loan to Infina Finance March 26, 2025 | 8:35 p.m. IST
Sun Pharma's Investee Lyndra Therapeutics To Cease Operations Due To Funding Issues March 26, 2025 | 4:30 p.m. IST
Sun Pharma Completes 100% Acquisition of Antibe Therapeutics for ₹27.5 Cr March 18, 2025 | 12:38 p.m. IST
Sun Pharma Releases 6,89,600 Pledged Shares, Strengthening Financial Position March 11, 2025 | 4:53 p.m. IST
Sun Pharma To Acquire Checkpoint Therapeutics For Up To ₹2,900 Cr To Boost Onco-Derm Portfolio March 10, 2025 | 7:11 a.m. IST
Sun Pharma Reports ₹478 Billion Sales for FY24 in Latest Investor Presentation March 4, 2025 | 5:13 p.m. IST
Sun Pharma Pledges 1,25,000 Shares as Loan Security for Third Party Financing March 4, 2025 | 10:14 a.m. IST
Sun Pharma Seeks Shareholder Nod for ₹11,069.5 Cr Related Party Transactions Involving Taro Subsidiaries February 20, 2025 | 5:04 p.m. IST
Sun Pharma Ranks in Top 5% of Global Pharmaceutical Firms for Sustainability in S&P Yearbook 2025 February 17, 2025 | 2:26 p.m. IST
Sun Pharmaceutical Makes Earnings Call Recording Available for Investors January 31, 2025 | 8:43 p.m. IST
Sun Pharma Reports Q3 FY2024 Net Profit of ₹1,181.05 Cr and Declares Interim Dividend of ₹10.50 January 31, 2025 | 8:29 p.m. IST
Sun Pharma Reports ₹32,196 Million Adjusted Net Profit in Q3 and Declares Interim Dividend of ₹10.50 Per Share January 31, 2025 | 3:22 p.m. IST
Sun Pharma Reports ₹32,196 Million Adjusted Net Profit for Q3, Declares Interim Dividend of ₹10.50 Per Share January 31, 2025 | 3:21 p.m. IST
Sun Pharmaceutical Secures Shareholder Approval for Composite Scheme of Arrangement Involving Amalgamation of Subsidiaries January 21, 2025 | 8:09 p.m. IST